Abstract: The present invention relates to replication protein A (RPA) transcriptional factors. There is provided a nucleotide sequence encoding a replication protein A transcriptional activator 1 (RTB1) and a protein encoded by such a nucleotide sequence. RBT1 has a high activity and is highly transactivated in cancer cells. The sequence may be used to treat neoplastic disorders and in gene therapy.
Type:
Grant
Filed:
August 17, 2000
Date of Patent:
August 22, 2006
Assignee:
Center for Translation Research in cancer
Inventors:
Moulay A. Alaoui-Jamali, John Myung-Jae Cho